Trial Profile
A phase II study of goserelin acetate (Zoladex) in recurrent or persistent endometrial cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2005
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 23 Dec 2005 New trial record.